Board of Registered Nursing tells IECs to stop blanket requirement that participants work in bedside roles or "pass narcotics" without patient-safety evidence

The Board of Registered Nursing (BRN) on Sept. 12 directed Intervention Evaluation Committees (IECs) to stop imposing, as a blanket rule, requirements that nurses in the intervention program return to direct patient-care roles or obtain access to narcotics unless there is documented evidence of patient-safety concerns.

John Gorney, intervention analyst for the BRN, read the board motion to the committee: “suspend the imposition of the requirement that participants work in direct patient care unless there is additional evidence of patient safety issues.” The statement was presented as the board's guidance to IECs for how completion requirements should be applied.

The guidance matters because IEC decisions determine whether nurses in BRN’s voluntary intervention program have met conditions to demonstrate safe practice and regain full practice privileges. Committee members heard staff say the board’s intent is rehabilitative: program completion should focus on evidence of recovery and safety rather than automatic placement back into bedside roles when that placement is not supported by patient-safety documentation.

Executive Officer Loretta (Laurie) Melby told the IEC that staff reviewed prior practices after complaints that vendors and panels had been imposing blanket requirements. Melby said BRN staff reviewed cases with the vendor Maximus, participants, IEC members and others, and found inconsistent documentation supporting the requirement to return to direct-patient care or to have narcotics access. She told the committee staff returned many IEC recommendations for reconsideration when the record lacked evidence justifying those work requirements.

Melby provided case counts for staff review: 56 participant reviews were referred to BRN staff under the board’s direction; of those, 19 recommendations had documentation sufficient to support work or narcotics-access requirements, while 31 lacked documentation and were sent back to IECs for reconsideration.

Melby emphasized that Uniform Standard 12 (the board’s clinical-safety standard cited during the meeting) requires evidence that a nurse can “practice safely” and that IECs retain discretion to impose work-related limits when the record shows patient-safety risk. She urged IECs to document the specific patient-safety findings that would justify requiring return to bedside practice or access to controlled substances.

Staff described operational next steps: BRN will increase IEC training and make staff available in IEC open sessions to answer questions; BRN also will continue outreach (the board reported emailing outreach materials to hundreds of nurses this year) and is actively recruiting to fill IEC vacancies. The BRN reminded members that intervention records for participants who successfully complete the program must be purged under board rule 70.12, a point raised to underscore confidentiality protections and to explain why IECs often do not have access to prior successful-participation records unless the participant discloses them.

Committee members asked practical questions about participants who are unable to work for medical reasons, nurses who have been in the program previously, and how to handle specialty changes or new-to-specialty onboarding. Melby said such cases are handled case-by-case: a participant’s inability to work for health reasons does not automatically prevent completion if alternative evidence demonstrates safety. She also noted the board is considering regulatory language changes to clarify whether completion should focus on safe medication administration broadly rather than on the narrow phrase “passing narcotics.” Any regulatory change would require subject-matter evidence and a formal rulemaking process.

Melby also noted BRN’s participation in a National Council of State Boards of Nursing (NCSBN) study on recidivism for nurses who return to practice after completing programs; final results are expected in roughly two years and could inform future policy.

The committee did not take formal rulemaking action during the Sept. 12 meeting. Instead, staff asked IEC members to review the IEC guidance materials, provide feedback to staff on where additional information is needed, and to expect more training opportunities and staff participation in IEC meetings so that documentation standards for patient-safety justifications are clearer.

Looking ahead, BRN staff said the next IEC 12 meeting is scheduled for Wednesday, December 2 at the Department of Consumer Affairs, Pearl Room, 1747 North Market Boulevard, Suite 100, Sacramento. The committee was reminded that IEC meetings must meet Bagley-Keene open meeting requirements and require at least three members to convene.

The discussion closed with staff reiterating that the board’s priority is public protection and that IECs should tie any work or narcotics-access requirements to documented patient-safety evidence rather than a blanket practice applied to all program participants.